EKF Diagnostics Holdings plc (AIM:EKF)
London · Delayed Price · Currency is GBP · Price in GBX 26.40
+0.90 (3.53%)
Dec 31, 2025, 12:50 PM GMT+1
EKF Diagnostics Holdings Market Cap
EKF Diagnostics Holdings has a market cap or net worth of 114.9 million as of December 31, 2025. Its market cap has increased by 0.29% in one year.
Market Cap
114.90M
Enterprise Value
100.56M
Revenue
50.22M
Ranking
n/a
PE Ratio
19.54
Stock Price
26.40
Market Cap Chart
Since June 30, 2003, EKF Diagnostics Holdings's market cap has increased from 2.27M to 114.90M, an increase of 4,954.01%. That is a compound annual growth rate of 19.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 114.90M | -6.21% |
| Dec 31, 2024 | 122.51M | -14.69% |
| Dec 29, 2023 | 143.61M | -36.87% |
| Dec 30, 2022 | 227.47M | -34.63% |
| Dec 31, 2021 | 347.95M | 6.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 213.19B |
| GSK plc | 73.15B |
| Haleon | 33.22B |
| Smith & Nephew | 10.37B |
| Convatec Group | 4.74B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 1.73B |
| HUTCHMED (China) | 1.71B |